Response to Mosunetuzumab in Patients with B-Cell Lymphomas Relapsed or Refractory after CAR-T Cell Therapy Is Associated with Changes in Lymphocyte Counts

被引：0

作者：

Chong, Elise A. ^{[1
]}

Penuel, Elicia ^{[2
]}

Bartlett, Nancy L. ^{[3
]}

Bosch, Francesc ^{[4
]}

Budde, L. Elizabeth ^{[5
]}

Fay, Keith ^{[6
,7
]}

Flinn, Ian W. ^{[8
]}

Goy, Andre ^{[9
]}

Kumar, Anita ^{[10
]}

Lundberg, Rachel ^{[1
]}

Napier, Ellen B. ^{[1
]}

Nastoupil, Loretta J. ^{[11
]}

Shadman, Mazyar ^{[12
]}

Wei, Michael C. ^{[2
]}

Wu, Mei ^{[2
]}

Yin, Shen ^{[2
]}

Chong, Emeline R. ^{[1
]}

Schuster, Stephen J. ^{[1
]}

机构：

[1] Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USA

[2] Genentech Inc, San Francisco, CA USA

[3] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA

[4] Hosp Univ Vall dHebron, Vall dHebron Inst Oncol VHIO, Dept Hematol, Barcelona, Spain

[5] City Hope Natl Med Ctr, Dept Hematol & HCT, 1500 E Duarte Rd, Duarte, CA 91010 USA

[6] St Vincents Hosp, Sydney, NSW, Australia

[7] Royal North Shore Hosp, Sydney, NSW, Australia

[8] TriStar Centennial Med Ctr, Sarah Cannon Transplant & Cellular Therapy Progra, Nashville, TN USA

[9] Hackensack Meridian Hlth, Lymphoma Div, John Theurer Canc Ctr, Hackensack, NJ USA

[10] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, Short Hills, NJ USA

[11] MD Anderson Canc Ctr, Houston, TX USA

[12] Fred Hutchinson Canc Res Ctr Seattle, Seattle, WA USA

来源：

关键词：

D O I：

10.1182/blood-2023-190201

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5